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Introduction
　Branching morphogenesis (BrM) is one of the 
basic processes for the formation of many organs, 
such as the lungs, the kidneys, and all exocrine 
glands including the three major salivary glands. 
The submandibular gland (SMG) of the fetal 
mouse is a widely used model system to study 
BrM, since it is capable of undergoing branching 
in vitro1,2.  The mouse SMG initiates development 
on day 12 of gestation (E12 ; the day of discovery 
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Abstract : Branching morphogenesis of the fetal mouse submandibular gland (SMG) is regulated 
by signaling through the ErbB and FGF families of tyrosine kinase receptors, whose members acti-
vate the ERK-1/2 pathway.  The four Sprouty (Spry) proteins are inhibitory modulators of ERK-1/2.  
There is little information on their expression during pre- and postnatal development of the SMG.  
Qualitative RT-PCR detected mRNAs for Spry1, 2, and 4 from embryonic day 13 (E13) through 
postnatal day 7 (P7), but only trace amounts of Spry1 and 2 in adult SMGs.  More sensitive quanti-
tative RT-PCR revealed that transcripts for all four Spry isoforms are expressed, and each shows 
individual patterns of variation across fetal and early postnatal stages, and that there are very low 
levels of Spry1 and 2, but no Spry3 and 4, in adult glands.  EGF, FGF7 and FGF10 upregulate ex-
pression of mRNA for Spry1, but only FGF7 upregulates Spry2 mRNA.  EGF strongly induces an 
activating phosphorylation of all four Spry isoforms, but both FGFs do so only minimally.  Quanti-
tative RT-PCR of samples collected by laser capture microdissection showed that transcripts for 
Spry1 are conﬁned to the epithelium of E13 SMG rudiments.  The isoform-speciﬁc temporal varia-
tion in the patterns of expression of Spry1, 2, 3 and 4 suggests a potentially important role for 
these negative modulators of growth-factor driven ras/ERK-1/2 signaling at stages when the SMG 
is most actively undergoing branching morphogenesis.
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of vaginal plug was taken as E0) as a downgrowth 
of the oral epithelium into the underlying mesen-
chyme, forming an elongated stalk ending in an 
expanded endbud.  A cleft develops on the distal 
tip of the endbud, and the epithelium bifurcates 
as two epithelial stalks elongate from this site and 
again end in expanded endbuds.  This process of 
clefting and elongation of the epithelium is done 
repeatedly until the ﬁnal appropriate extent of 
branching is reached.  Eventually the elongated 
portions form lumens and become ducts, and the 
endpieces differentiate into acini.  This process is 
dependent on epitheliomesenchymal interactions 
mediated by integrins and extracellular matrix, 
and growth factors and their receptors3,4.
　Several growth factors are known to be required 
for full development of the fetal SMG, including 
EGF5, FGF6, and PDGF7.  The members of all 
three of these families of ligands activate mem-
brane spanning receptors that are tyrosine 
kinases (RTKs), that trigger intracellular signal-
ing cascades8.  The most commonly used pathways 
are those leading to activation of ERK-1/2, PLCγ1, 
and PI3K/Akt.  All three of these signaling cas-
settes have been shown to be important for BrM of 
the fetal mouse SMG9-11.
　Sprouty (Spry) was ﬁrst discovered as an antag-
onist of ﬁbroblast growth factor (FGF) signaling in 
branching of Drosophila airway, and of epidermal 
growth factor (EGF) signaling in eye and wing 
development via inhibition of the Ras/Raf/MEK/
ERK pathway12.  There are four member of the 
Spry family called Spry1, 2, 3, and 4, and they 
have been shown to be general inhibitors of RTK 
signaling mediated by the Ras/Raf/MEK/ERK 
pathway13,14.  It is known that the phosphorylation 
of tyrosine residues of Spry molecules is required 
for their activation.  However, depending on the 
phosphorylation site, the functions of the individ-
ual Spry proteins vary15.
　Expression of Spry genes 1, 2, and 4 has been 
detected in the perinatal mouse SMG epithelium 
by in situ hybridization16.  However, nothing fur-
ther is known about these proteins in the develop-
ment of the SMG.  To further analyze possible 
roles for these negative modulators of the ras/
ERK-1/2 pathway activated by many of the growth 
factor systems regulating development of this 
gland, we have examined expression of the four 
Spry isoforms across the entire time span of the 
gland's fetal development, and in early postnatal 
life and in adults.
Materials and Methods
1. Materials
　Recombinant EGF, FGF7, and FGF10 were pur-
chased from R & D Systems Inc. (Minneapolis, 
MN, USA).  Anti-Spry1, 2, 3 and 4 antibodies were 
from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA), and Protein G magnetic beads were from 
New England Biolabs (Ipswich, MA, USA).
2. Organ culture
　Pregnant mice (ICR strain) were purchased 
from Japan SLC Inc. (Hamamatsu, Japan).  The 
day of discovery of the vaginal plug was taken as 
embryonic day 0 (E0).  The SMGs were removed 
from prenatal (E13 to E18) and postnatal (7 days 
and adult) mice.
　SMG rudiments were cultured as described pre-
viously17.  Brieﬂy, approximately 20 SMGs were 
taken at E13 (one pregnant mouse), and placed on 
a membrane ﬁlter (Nuclepore membrane, 0.1 μm 
pore size ; Whatman International, Brantford UK) 
ﬂoating on 400 μl of DMEM/F-12 medium (GIBCO 
Invitrogen Cell Culture, Carlsbad, CA, USA) con-
taining 100 units/ml penicillin (GIBCO Invitrogen 
Cell Culture), 100 μg/ml streptomycin (GIBCO 
Invitrogen Cell Culture), 150 μg/ml vitamin C 
(Sigma, St. Louis, MO, USA), and 50 μg/ml trans-
ferrin (Sigma).  The SMGs were precultured for 3 
hrs on the ﬁlters in organ-culture dishes (Falcon 
Becton and Dickinson Labware, Franklin Lake, NJ, 
USA) ; then EGF (50 ng/ml), FGF7 (200 ng/ml) 
or FGF10 (500 ng/ml) was added to the medium, 
and the rudiments were cultured in 5％ CO2/95％
air and 80％ humidity at 37℃.  The experiments 
were repeated ﬁve times (5 pregnant mice were 
used).
　All procedures of animal handling were con-
ducted in accordance with the Guideline for 
Experimental Animals of Asahi University (Proto-
col No. 07-011).
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3.  Total RNA preparation and qualitative 
RT-PCR
　Total RNA was extracted from SMGs using TRI 
Reagent (Sigma) following the manufacturer's 
instructions.  The following numbers of SMGs 
were used, with 20-34 SMG rudiments obtained 
per liter : E13, 6 pregnant mice ; E14, 2 pregnant 
mice ; E15-P7, one pregnant mouse at each age ; 
Ad, 3 mice.  Total RNA extracts were then dis-
solved in nuclease-free H2O and digested by 
DNase I to remove possible DNA contamination. 
The total RNA (3 μg) was reverse transcribed to 
cDNA by a Super Script First Strand Synthesis 
System for RT-PCR (GIBCO Invitrogen Cell Cul-
ture) as described previously5.  PCR was carried 
out in triplicate with the following primers : 
mouse Spry1 (Acc#; NM_011896), forward 5'- 
GAAAGGACTCATGAAATCATACC-3' and reverse 
5'-GTTATCCGAGTAAGAACCTC-3' ; mouse Spry2 
(Acc# ; NM_011897), forward 5'-AAGCCGACATA 
GCATTATTAATCA-3' and reverse 5'-TGAATT 
GTAGCAAGCGTATCA-3' ; mouse Spry3 (Acc# ; 
NM_001030293), forward 5'-CGCTCTACTCACG 
CTAGCA-3' and reverse 5'-CCTTCAGAGCACCA 
TCGAC-3'; mouse Spry4 (Acc#; NM_011898), for-
ward 5'-GGCCTGTGGAAAGTGTAAGT-3' and 
reverse 5'-CCGGTTTCTTCCCAATCTAGG' ; and 
mouse β-actin (Acc# ; NM_007393), forward 5'- 
GTGACGTTGACATCCGTAAAGA-3' and reverse 
5'-CTCAGGAGGAGCAATGATCTT-3'.  The PCR 
reactions were carried out for 35 cycles at an ini-
tial denaturing temperature of 95℃ for 5 min and 
a ﬁnal extension at 72℃ for 10 min.  Each cycle 
had a denaturing temperature of 94℃ for 1 min, 
an annealing temperature speciﬁc for each primer 
pair for 1 min, and an extension temperature of 
72℃ for 2 min.  The annealing temperatures were 
50℃ for Spry1 and 2, 58℃ for Spry3 and β-actin, 
and 54℃ for Spry4.
4. Quantitative RT-PCR
　For each PCR tube, 1.0 μl cDNA from the above 
reverse transcriptase reaction mixture (Super-
script) was mixed with 0.5 pmole primers (forward 
and reverse) and 12.5 μl iQ SYBR Green Super-
mix (Bio-Rad Laboratories, Hercules, CA, USA). 
Primer pairs and temperatures were as follows : 
mouse Spry1, forward 5'-GAGGTTCTTACTC 
GGATAAC-3' and reverse 5'-GGTCCAGTCGT 
AACAGC-3' ; mouse Spry2, forward 5'-AAAGC 
CGACATAGCATTATTAATCA-3' and reverse 
5'-GCAAACCACAAATCCCCTA-3' ; mouse Spry3, 
forward 5'-AGCCAGTCTAGTATTTCCAGCT-3' 
and reverse 5'-AGAGCACCATCGACCTTTG-3' ; 
mouse Spry4, forward 5'-CTCCTAGATCACAT 
GGCTCC-3' and reverse 5'-GTGCTTGTCTAGCTC 
TGGC-3'; and mouse β-actin, forward 5'-GTGAC 
GTTGACATCCGTAAAGA-3' and reverse 5'- 
CTCAGGAGGAGCAATGATCTT-3'.  The PCR 
reactions were carried out for 40 cycles at an ini-
tial denaturing temperature of 95℃ for 5 min and 
a ﬁnal extension at 72℃ for 10 min.  Each cycle 
had a denaturing temperature of 94℃ for 10 sec, 
an annealing temperature speciﬁc for each primer 
pair for 30 sec, and an extension temperature of 
72℃ for 30 sec.  The annealing temperatures were 
56℃ for Spry1, 2, 3 and 4, 52℃ for β-actin.  The 
reactions were carried out in a DNA Engine Opti-
con System (Bio-Rad) and results were analyzed 
with Opticon Monitor Analysis Software (Bio-Rad). 
The ampliﬁcation amount of each Spry reaction 
was compared to the amount of β-actin ampli-
ﬁcation as an internal standard, and the ﬁnal 
results were expressed as the ratio of these two 
amounts.
5.  Metabolic labeling of Spry proteins with 
32P
　E13 SMG rudiments were collected from four 
pregnant mice (128 SMGs) and preloaded with 
radioisotope by culture under the above condi-
tions for 2.5 h in medium containing 0.5 mCi/ml 
32P-orthophosphoric acid, before addition of EGF, 
FGF7 or FGF10 at the concentrations used above, 
and culture was continued for 30 min.  Incubation 
was terminated by washing the tissues on the ﬁl-
ters with ice-cold PBS containing 1 mM Na3V04, 
and the SMG rudiments were collected and 
homogenized in 50 mM Tris-HCl (pH 7.4), 150 mM 
NaCl, 1 mM EDTA, 1％ Triton X-100, 2.5 mM Na-
pyrophosphate, 1 mM β-glycerophosphate, pro-
tease inhibitor cocktail (Sigma) and phosphatase 
inhibitor cocktail 2 (Sigma), and supernatants 
were processed for immunoprecipitation, as 
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described previously5.  Equal amounts of radioac-
tivity (1.77 × 105 cpm) were used for immunopre-
cipitation, and the precipitates were resolved by 
SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and the gels were dried and exposed to 
X-ray ﬁlm.
6. Laser capture microdissection
　SMG rudiments were collected from E13 mice 
(96 SMGs) and embedded into OCT compound, 
and frozen sections (8 μm) were cut in a cryostat. 
The SMG sections were stained with crystal violet 
(LCM Staining Kit, Ambion).  From each section, 
samples were collected from three epithelial sites 
and one mesenchymal site, each containing about 
500 cells, using Laser Capture Microdissection 
(PALM-MBIII, P.A.L.M. Microlaser Technologies 
AG, Germany).  The three epithelial samples were 
from (1) ducts, (2) endbud epithelium in contact 
with mesenchyme, and (3) inner epithelial cells 
of the endbud (see Fig. 6A).  Total RNAs were pre-
pared from the captured cells using a RNeasy 
Micro Kit (QIAGEN Sciences, Germantown, MD, 
USA), and then cDNA synthesis and real-time RT-
PCR were performed as described above.
Results
1. RT-PCR analyses of Spry isoforms
　Qualitative RT-PCR of total RNA from intact 
submandibular glands from embryonic day 13 to 
18 (E13 to E18), and from newborns (NB), postna-
tal day 7 (P7), and adults detected mRNAs for 
Spry1, 2, and 4, but not for Spry3 (Fig. 1).
　Quantitative real-time RT-PCR conﬁrmed the 
presence of transcripts for Spry1, 2, and 4 and 
also detected the mRNAs for Spry3 (Fig. 2).  The 
Fig. 1　RT-PCR for Spry1, 2, and 4 in developing mouse 
SMG. Total RNAs from SMGs of E13-E18, new 
born (NB), postnatal day 7 (P7) and adult (Ad) 
were transcribed to cDNA, and the target se-
quences were ampliﬁed with each speciﬁc primer 
for target sequences. The PCR products were sub-
jected to agarose gel electrophoresis and visual-
ized using ethidium bromide. The experiments 
were repeated three times.
Fig. 2　Quantitative analyses of Spry mRNAs in developing mouse SMG by real-time RT-PCR. The ampliﬁcation amount of 
each of the Spry cDNAs (A : Spry1, B : Spry2, C : Spry3, and D: Spry4) which were synthesized from E13-E18, new 
born (NB), postnatal day 7 (P7) and adult (Ad) mouse SMGs using reverse transcriptase were analyzed. Amount of 
each Spry gene was expressed as the ratio of the amounts of Spry and β-actin cDNAs. The experiments were repeat-
ed three times, with four SMGs per age group.
51November, 2010 Spry Isoforms in Fetal Mouse SMG
pattern of expression is speciﬁc for the mRNA of 
each isoform across the course of the gland's 
development.  Spry1 mRNA is expressed at an 
unchanging level from E13 through P7, but is dra-
matically reduced in adult glands (Fig. 2A).  Lev-
els of Spry2 transcripts are high at E13 and E14, 
then decline from E15 to birth, rise again at P7, 
and are lowest in adult glands (Fig. 2B).  Spry3 
transcripts are highest at E13, but remain low 
from E14 to birth ; there is a slight increase at P7, 
but they are essentially absent in adults (Fig. 2C). 
Spry4 mRNA levels are highest at E13 and gradu-
ally decline thereafter, and are apparently absent 
in the adult (Fig. 2D).  The ranges of CT (CT＝
25-29) values for Spry1 and Spry2 are lower than 
those of Spry3 and Spry4.
2.  Morphological changes by three major 
growth factors
　Spry proteins are speciﬁc inhibitors of the Raf-
ERK-1/2 intracellular signaling cascade, which is 
activated by many receptor tyrosine kinases, 
including both the ErbB and FGFR families of 
receptors.  As previously reported by us and oth-
ers5,18,19, EGF increases branching morphogenesis 
in E13 SMGs cultured in vitro (Fig. 3A, B), but the 
two FGF have only a slight or minimal effect on 
this process in this gland (Fig. 3C, D).
3.  Inductions of transcription and phospho-
rylation of Spry mRNA by growth factors
　We found, furthermore, that all three of these 
ligands of these two RTK families signiﬁcantly 
upregulate expression of Spry1 and Spry2 
mRNAs, with FGF7 having the strongest effect 
(Fig. 4A, B).  Spry proteins must be phosphory-
lated in order for them to inhibit Raf-ERK-1/2 sig-
naling20.  However, levels of Spry proteins are very 
low, and are very difﬁcult to detect by immunob-
lotting studies.  To determine if these proteins are 
phosphorylated in response to EGF or FGF7 or 
FGF10, we exposed E13 SMGs to these growth 
Fig. 3　Effect of EGF, FGF7 or FGF10 on morphogene-
sis of E13 SMG in vitro. E13 SMG rudiments 
were cultured with none (A), EGF (B, 50 ng/ml), 
FGF7 (C, 200 ng/ml) or FGF10 (D, 500 ng/ml). 
The photographs were taken after 48 hrs cul-
ture. Original magniﬁcation 60 ×. Bar, 0.5 mm. 
This experiment was repeated ﬁve times.
Fig. 4　Upregulation of Spry1 and Spry2 gene expressions 
in cultured E13 SMG by administration of EGF, 
FGF7 or FGF10. E13 SMG rudiments were cul-
tured for 24 hrs with none (control), EGF (20 ng/
ml), FGF7 (200 ng/ml) or FGF10 (500 ng/ml). 
Amounts of Spry1 and 2 genes were expressed as 
the ratio of amounts of Sprys and β-actin cDNA. 
The experiments were repeated three times, with 
5 SMGs per group. ＊p＜ 0.05 and ＊＊p＜ 0.01 as 
compared with the control value ; Student's t-test.
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factors in the presence of 32P-orthophosphate.  The 
supernatants of these glands were then subjected 
to immunoprecipitation with antibodies speciﬁc 
for each of the four Spry isoforms, and the immu-
noprecipitates were resolved by electrophoresis 
and transferred to membranes for autoradiogra-
phy.  The radioactive tag greatly improved the 
sensitivity of these immunoprecipitation tech-
niques, and all four Spry isoforms were then 
detectable in the fetal SMGs (Fig. 5).  EGF had 
the greatest effect and strongly phosphorylated all 
four Spry proteins.  FGF7 mildly stimulated 
Spry2, 3 and 4, and FGF10 had a slightly greater 
effect on Spry1 and 3.
4.  Localization of Spry transcript in E13 SMG 
rudiments
　Since levels of the Spry proteins are so low, we 
were unable to demonstrate their tissue localiza-
tion by immunocytochemical techniques (data not 
shown).  Thus, we probed the cellular localization 
by laser capture microdissection and RT-PCR. 
Samples were chosen from four sites (Fig. 6A) : the 
epithelium of ducts, the outer epithelium of the 
endbud in contact with mesenchyme, the inner 
endbud epithelium, and the mesenchyme.  All 
three epithelial compartments showed the same 
amount of Spry1 transcripts, but the mesenchyme 
had only negligible message (Fig. 6B).
Discussion
　The present ﬁndings demonstrate that the four 
members of the Spry family are expressed in the 
fetal SMG, that mRNAs for Spry1, 2 and 4 are 
Fig. 5　Phosphorylation of Spry proteins in cultured E13 
SMG stimulated by EGF, FGF7 or FGF10. E13 
SMG rudiments were precultured with 0.5 mCi/ml 
32P-orthophosphoric acid, and then culture was 
continued with no addition (control), EGF (20 ng/
ml), FGF7 (200 ng/ml) or FGF10 (500 ng/ml). After 
30 min stimulation, SMGs were collected and ho-
mogenized. Phosphorylated Spry protein in the 
homogenates was immunoprecipitated using each 
speciﬁc Spry antibody and subjected to SDS-
PAGE. The 32P-radiolabeled proteins in the dried 
gels were detected by exposure to X-ray ﬁlm 
(Kodak XAR). Phosphorylated Spry1-4 proteins 
were estimated at about 35 kD by SDS-PAGE 
analysis.
Fig. 6　Preparation of total RNA from the cells of E13 
SMG rudiments using laser capture microdissec-
tion and estimation of the amount of Spry1 mRNA 
by real-time RT-PCR. (A) From the stained SMG 
sections, samples were collected from one mesen-
chymal site and three epithelial sites : (1) ducts, (2) 
endbud epithelium in contact with mesenchyme, 
and (3) inner epithelial cells of the endbud. (B) 
The extracted total RNAs were reverse tran-
scribed to cDNA and the amount of each Spry 
gene was analyzed by real-time RT-PCR. The 
amount of Spry1 gene was expressed as the ratio 
of amounts of Spry1 and β-actin cDNAs. The ex-
periments were repeated four times. ＊＊p＜ 0.01 
as compared with the value of ductal epithelium 
(lowest value) ; Student's t-test.
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present at higher levels than the mRNA for Spry3, 
and that EGF or FGF7 or 10 not only upregulate 
expression of these genes, but also can stimulate 
phosphorylation and activation of these proteins.
　The present study is the ﬁrst to measure the 
amounts of mRNAs for Spry1, 2, 3, and 4 that 
are endogenously expressed at all developmental 
stages in the mouse SMG.  The results of real-
time RT-PCR showed that mRNAs for Spry1, 2, 3, 
and 4 were expressed in the SMG rudiments from 
E13 to E18 and newborn, postnatal 7 days and 
adult mice.  All Spry mRNAs were decreased at 
adult ages.  Because mRNAs of Spry1, 2, 3, and 4 
are highly expressed in fetal and early postnatal 
stages, they most likely are involved mainly in 
modulating developmental processes of fetal 
mouse SMGs.
　Spry transcripts are known to localize to epithe-
lium in developing mouse SMG, lung, kidney, and 
tooth by in situ hybridization16.  The transcripts 
were most strongly expressed in the distal leading 
tips of the epithelial endbuds of the SMG and 
lung, but were not seen in the mesenchyme.  We 
collected total RNA from epithelial and mesenchy-
mal tissues from E13 SMG sections using Laser 
Capture Microdissection, and we showed that 
Spry1 is highly expressed in epithelium by real-
time RT-PCR, but not in the mesenchyme, consis-
tent with Zhang et al.16
　Mailleux et al.21 reported that both Spry2 mRNA 
expression and the size of the epithelial endbuds 
are increased in E12 lung rudiments cultured in 
the presence of FGF10.  Spry2 most likely regu-
lates organogenesis of the lung by suppressing 
ERK signals stimulated by FGF10.  Mai et al.22 
reported agenesis of the SMG and lacrimal glands 
in mice with a missense mutation in the Fgfr2 
gene.  Patel et al.23 found increased levels of the 
mRNAs for Spry1 and 2, but not Spry4, in mesen-
chyme-free fetal SMG epithelium in Matrigel cul-
tured in the presence of a synthetic sulfated oligo-
saccharide, which presumably forms a complex 
with FGFs to activate the FGFR1b.
　However, there has been no information about 
the actual amounts of the mRNAs for Spry iso-
forms induced by direct stimulation by growth fac-
tors in the developing mouse SMG.  We showed 
that mRNAs for Spry1 and Spry2 were signiﬁ-
cantly increased by the administration of EGF, 
FGF7 or FGF10 in E13 SMG rudiments.  These 
data suggest complex regulatory interactions 
between these growth factors and these downregu-
lators of ERK-1/2 signaling during organogenesis 
of fetal mouse SMG.
　Other investigators using cultured cell systems 
found that several growth factors were able to 
stimulate the phosphorylation of tyrosine residues 
of Spry proteins, and these phosphorylations are 
known to be required to activate the inhibitory 
functions of Spry proteins.  In this study, we 
showed that all three growth factors (EGF, FGF7 
and FGF10) stimulated phosphorylation of Spry1, 
2, 3, and 4.  EGF was the strongest stimulator for 
the phosphorylation of Sprys, whereas the two 
FGFs were weaker stimulators, and had no effect 
on Spry2.  These results imply that the modulat-
ing effects of Sprys on ERK signaling would vary 
depending on which growth factor is active in trig-
gering this intracellular signaling cascade, and 
may be relevant in explaining differences in mor-
phogenesis events in fetal mouse SMGs induced 
by different growth factors, such as EGF or the 
FGFs.
　There results show that the levels of expression 
and/or phosphorylation of Sprys are regulated by 
the growth factors, and that the Spry isoforms 
may function as modulators of development of the 
mouse SMG through modulating the ras/ERK-1/2 
signaling network.  Given that Spry proteins act 
as inhibitory modulators of the Raf-ERK-1/2 sig-
naling pathway that is involved in many networks 
triggered by many RTKs responsive to a wide 
variety of growth factors, it is at present not possi-
ble to deﬁne the precise roles that Spry proteins 
play in the fetal mouse SMG, but their presence 
unquestionably has functional importance since 
the levels of individual Spry isoforms differ from 
each other across development.  The observation 
that the growth factors used in this study resulted 
both in increased phosphorylation and activation 
of ERK1/2, as well as increased expression of the 
Spry isoforms, suggests that the latter may be act-
ing as modulators in negative feedback loops in 
this signaling cascade.  There are no known inhib-
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itors of the Spry family members, so an approach 
using siRNAs would likely be most effective in 
pursuing these investigations17.  Indeed, by using 
knockout or transgenic mice for Spry1 it has been 
demonstrated that this isoform acts to oppose and 
balance the stimulatory effects of GDNF on 
branching morphogenesis in the developing kid-
ney24.  It is reasonable to suggest that the Spry 
family of proteins may play similar roles in the 
developing SMG.
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